JAK/STAT signaling pathway-mediated microRNA-181b promoted blood-brain barrier impairment by targeting sphingosine-1-phosphate receptor 1 in septic rats.
JAK/STAT signaling pathway-mediated microRNA-181b promoted blood-brain barrier impairment by targeting sphingosine-1-phosphate receptor 1 in septic rats.
复制标题
JAK/STAT信号通路介导的microRNA-181b通过靶向1-磷酸鞘氨醇受体1促进脓毒症大鼠血脑屏障损伤
DOI:
10.21037/atm-20-7024
复制
发表时间:
2020-11
影响因子:
--
通讯作者:
Wen MY
中科院分区:
文献类型:
--
作者:
Chen SL;Cai GX;Ding HG;Liu XQ;Wang ZH;Jing YW;Han YL;Jiang WQ;Wen MY
Background Blood-brain barrier (BBB) impairment plays a significant role in the pathogenesis of sepsis-associated encephalopathy (SAE). However, the molecular mechanisms are poorly understood. In the present study, we aimed to investigate the regulatory relationship between the Janus kinase/signal transducers and activators of transcription (JAK/STAT) signaling pathway, microRNA (miR)-181b and its target genes in sepsis in vivo and in vitro. Methods Four rat models (sham, sepsis, sepsis plus STAT3 inhibitor (Stattic), and sepsis plus miR-181b inhibitor [sepsis + anta-miR-181b]) were established. For the in vitro experiments, rat brain microvascular endothelial cells (rBMECs) and rat brain astrocytes (rAstrocytes) were cultured with 10% serum harvested from sham, sepsis, and sepsis + anta-miR-181b rats. Chromatin immunoprecipitation-quantitative polymerase chain reaction (ChIP-QPCR) analysis was carried out to detect the binding and enrichment of the JAK/STAT3 signal core transcription complex in the miR-181b promoter region. Dual-luciferase reporter gene assay was conducted to test miR-181b and its target genes. The cell adhesion rate of rBMECs was also measured. Results During our investigations, the expression levels of miR-181b, p-JAK2, p-STAT3, and C/EBPβ were found to be significantly increased in the septic rats compared with the sham rats. STAT3 inhibitor halted BBB damage by downregulating the expression of miR-181b. In addition, miR-181b targeted sphingosine-1-phosphate receptor 1 (S1PR1) and neurocalcin delta (NCALD). The up-regulated miR-181b significantly decreased the cell adhesion rate of rBMECs. The administration of miR-181b inhibitor reduced damage to the BBB through increasing the expression of S1PR1 and NCALD, which again proved that miR-181b negatively regulates SIPR1 and NCALD to induce BBB damage. Conclusions Our study demonstrated that JAK2/STAT3 signaling pathway induced expression of miR-181b, which promoted BBB impairment in rats with sepsis by downregulating S1PR1 and decreasing BBB cell adhesion. These findings strongly suggest JAK2/STAT3/miR-181b axis as therapeutic target in protecting against sepsis-induced BBB damage.
登录
查看更多内容
影响因子:
11.1
作者:
Dan C;Jinjun B;Zi-Chun H;Lin M;Wei C;Xu Z;Ri Z;Shun C;Wen-Zhu S;Qing-Cai J;Wu Y
通讯作者:
Wu Y
影响因子:
4.1
作者:
Ding, Haixia;Huang, Zhen;Zhang, Junfeng
通讯作者:
Zhang, Junfeng
DOI:
10.4049/jimmunol.1302280
发表时间:
2014-12-01
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
Bosmann M;Russkamp NF;Strobl B;Roewe J;Balouzian L;Pache F;Radsak MP;van Rooijen N;Zetoune FS;Sarma JV;Núñez G;Müller M;Murray PJ;Ward PA
通讯作者:
Ward PA
影响因子:
4
作者:
Guo, Rui;Fan, Gang;Lu, Zhiming
通讯作者:
Lu, Zhiming
影响因子:
3.1
作者:
Feng, Anlin;Rice, Amanda D.;Wang, Ting
通讯作者:
Wang, Ting